Addiction medication shortages can be dangerous, as interruption of opioid substitution therapy risks relapse. Buprenorphine/naloxone (Suboxone) and naltrexone have faced UK supply issues.
Current Active Shortages (3)
Buprenorphine/naloxone (Suboxone® ) 2mg/500microgram and 8mg/2mg sublingual tablets
Medium DHSC MSNDepartment of Health and Social Care (DHSC) has issued a medicine supply notification for Buprenorphine/naloxone (Suboxone®) 2mg/500microgram and 8mg/2mg sublingual tablets. • Buprenorphine/naloxone (
Discontinuation of Subutex® and Suboxone® tablets
Active DHSC MSNDepartment of Health and Social Care (DHSC) has issued a medicine supply notification for Torasemide 10mg tablets • Torasemide 10mg tablets are in limited supply until March 2025. • Torasemide 5mg tab
Discontinuation of Subutex® and Suboxone® tablets
Active DHSC MSNUpdate 15/01/2026: DHSC has issued a Medicine supply Notification for Buprenorphine/naloxone (Suboxone® ) 2mg/500microgram and 8mg/2mg sublingual tablets.
What to Do If Affected
- Contact your drug treatment service immediately
- Don't stop opioid substitution therapy suddenly
- Emergency supplies may be available from your pharmacy
- Ask about switching between buprenorphine formulations
- Contact FRANK helpline: 0300 123 6600
Related Medicine Pages
Don't get caught off guard
Join 5,000+ patients getting early warning — 3 medicines went into shortage this week
Join free alerts →
Data sources: DHSC Medicine Supply Notifications · NHSBSA Serious Shortage Protocols · NHS England
Page last updated: 13 May 2026. Data checked daily.
Page last updated: 13 May 2026. Data checked daily.